Pavmed Inc (Pavmed) is a medical device company. It offers products such as EsoCheck which is a cell collection device; and EsoGuard which is a esophageal DNA test. It also has veris cancer care platform for personalized cancer care. The company serves healthcare providers and patients by offering devices that address significant medical conditions, aiming to improve procedural outcomes and reduce recovery times.The company has operations across US. Pavmed is headquartered in New York City, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pavmed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Pavmed Inc Company Overview
- Pavmed Inc Company Snapshot
- Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Pavmed Inc - Pipeline Analysis Overview
- Pavmed Inc - Key Facts
- Pavmed Inc - Major Products and Services
- Pavmed Inc Pipeline Products by Development Stage
- Pavmed Inc Ongoing Clinical Trials by Trial Status
- Pavmed Inc Pipeline Products Overview
- a/LCI + OCT Probe
- a/LCI + OCT Probe Product Overview
- Caldus - Renal Denervation
- Caldus - Renal Denervation Product Overview
- Caldus - Traditional Tissue Ablation
- Caldus - Traditional Tissue Ablation Product Overview
- DisappEAR
- DisappEAR Product Overview
- EsoCheck Cell Collection Device - Eosinophilic Esophagitis
- EsoCheck Cell Collection Device - Eosinophilic Esophagitis Product Overview
- EsoCure Esophageal Ablation Device
- EsoCure Esophageal Ablation Device Product Overview
- EsoGuard Esophageal DNA Test
- EsoGuard Esophageal DNA Test Product Overview
- EsoGuard Esophageal DNA Test Clinical Trial
- FlexMo
- FlexMo Product Overview
- Gen2 EsoCheck Balloon Sampling Device
- Gen2 EsoCheck Balloon Sampling Device Product Overview
- NextCath
- NextCath Product Overview
- NextFlo Intravenous Infusion Set
- NextFlo Intravenous Infusion Set Product Overview
- Non-Invasive Blood Glucose Measuring Device
- Non-Invasive Blood Glucose Measuring Device Product Overview
- Non-Invasive Diagnostic Test - BE Progression
- Non-Invasive Diagnostic Test - BE Progression Product Overview
- PortIO Device - Next Generation
- PortIO Device - Next Generation Product Overview
- PortIO Intraosseous Infusion System
- PortIO Intraosseous Infusion System Product Overview
- Pavmed Inc - Key Competitors
- Pavmed Inc - Key Employees
- Pavmed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Pavmed Inc, Recent Developments
- Apr 09, 2026: Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
- Mar 16, 2026: PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026
- Mar 12, 2026: Lucid Diagnostics to Hold Fourth-Quarter and Full-Year 2025 Business Update Conference Call and Webcast on March 26, 2026
- Jan 21, 2026: Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard
- Dec 09, 2025: Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
- Nov 12, 2025: Lucid Diagnostics Reports Third Quarter 2025 Financial Results
- Oct 29, 2025: Lucid Diagnostics To Hold Business Update Conference Call And Webcast On November 12
- Sep 25, 2025: Lucid Diagnostics Appoints John R. Palumbo to Board of Directors
- Aug 27, 2025: Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
- Aug 14, 2025: PAVmed Announces Business Update and Posts Q2 2025 Results
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Pavmed Inc Pipeline Products by Equipment Type
- Pavmed Inc Pipeline Products by Indication
- Pavmed Inc Ongoing Clinical Trials by Trial Status
- Pavmed Inc, Key Facts
- Pavmed Inc, Major Products and Services
- Pavmed Inc Number of Pipeline Products by Development Stage
- Pavmed Inc Pipeline Products Summary by Development Stage
- Pavmed Inc Ongoing Clinical Trials by Trial Status
- Pavmed Inc Ongoing Clinical Trials Summary
- a/LCI + OCT Probe - Product Status
- a/LCI + OCT Probe - Product Description
- Caldus - Renal Denervation - Product Status
- Caldus - Renal Denervation - Product Description
- Caldus - Traditional Tissue Ablation - Product Status
- Caldus - Traditional Tissue Ablation - Product Description
- DisappEAR - Product Status
- DisappEAR - Product Description
- EsoCheck Cell Collection Device - Eosinophilic Esophagitis - Product Status
- EsoCheck Cell Collection Device - Eosinophilic Esophagitis - Product Description
- EsoCure Esophageal Ablation Device - Product Status
- EsoCure Esophageal Ablation Device - Product Description
- EsoGuard Esophageal DNA Test - Product Status
- EsoGuard Esophageal DNA Test - Product Description
- EsoGuard Esophageal DNA Test - A Multicenter Case-control Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck, Versus Esophagogastroduodenoscopy, for the Diagnosis of Barrett's Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma
- EsoGuard Esophageal DNA Test - Genetic and Environmental Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
- EsoGuard Esophageal DNA Test - Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- EsoGuard Esophageal DNA Test - Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in Veterans
- EsoGuard Esophageal DNA Test - Nonendoscopic Screening for Barrett's Esophagus and Esophageal Cancer in At-Risk Veterans Without History of Chronic Gastroesophageal Reflux
- EsoGuard Esophageal DNA Test - Presence of Barrett's Esophagitis in a Cohort of People with Eating Disorders Who Engage in Purging Behaviors: a Pilot Study
- FlexMo - Product Status
- FlexMo - Product Description
- Gen2 EsoCheck Balloon Sampling Device - Product Status
- Gen2 EsoCheck Balloon Sampling Device - Product Description
- NextCath - Product Status
- NextCath - Product Description
- NextFlo Intravenous Infusion Set - Product Status
- NextFlo Intravenous Infusion Set - Product Description
- Non-Invasive Blood Glucose Measuring Device - Product Status
- Non-Invasive Blood Glucose Measuring Device - Product Description
- Non-Invasive Diagnostic Test - BE Progression - Product Status
- Non-Invasive Diagnostic Test - BE Progression - Product Description
- PortIO Device - Next Generation - Product Status
- PortIO Device - Next Generation - Product Description
- PortIO Intraosseous Infusion System - Product Status
- PortIO Intraosseous Infusion System - Product Description
- Pavmed Inc, Key Employees
- Pavmed Inc, Subsidiaries
- Glossary
- Pavmed Inc Pipeline Products by Equipment Type
- Pavmed Inc Pipeline Products by Development Stage
- Pavmed Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced BioMedical Technologies, Inc.
- Natera Inc
- Guardant Health Inc
